The interplay of drug therapeutics and immune responses to SARS-CoV-2

被引：4
|
作者：
Fumagalli, Valeria [1 ,2 ]
Iannacone, Matteo [1 ,2 ,3 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, Milan, Italy
来源：
CELLULAR & MOLECULAR IMMUNOLOGY | 2024年 / 21卷 / 02期
基金：
欧洲研究理事会;
关键词：
SARS-CoV-2; Nirmatrelvir; Bisphosphonates; Adaptive immunity; Drug repurposing; ZOLEDRONIC ACID; BISPHOSPHONATE THERAPY; CELLS; MECHANISMS; MONOCYTES; SAFETY;
D O I：
10.1038/s41423-023-01098-7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The SARS-CoV-2 pandemic has necessitated rapid therapeutic and preventative responses. While vaccines form the frontline of defense, antiviral treatments such as nirmatrelvir have emerged as vital adjunctive measures, particularly for those unable or unwilling to be vaccinated. This review delves into the potential influence of nirmatrelvir on enduring immunity. In parallel, the potential of drug repurposing is explored, with bisphosphonates being examined for their possible effects against COVID-19 due to their immunomodulatory properties. The importance of rigorous clinical trials and careful interpretation of preliminary data is emphasized.
引用
收藏
页码：197 / 200
页数：4
相关论文
共 50 条
  • [31] Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?
    A. Guillon
    P. S. Hiemstra
    M. Si-Tahar
    Intensive Care Medicine, 2020, 46 : 1897 - 1900
  • [32] Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination
    Riccomi, A.
    Trombetta, C. M.
    Dorrucci, M.
    Di Placido, D.
    Sanarico, N.
    Farchi, F.
    Giuseppetti, R.
    Villano, U.
    Marcantonio, C.
    Marchi, S.
    Ciaramella, A.
    Pezzotti, P.
    Montomoli, E.
    Valdarchi, C.
    Ciccaglione, A. R.
    Vendetti, S.
    VACCINES, 2024, 12 (04)
  • [33] An Update on Innate Immune Responses during SARS-CoV-2 Infection
    Zhang, Yu
    Chen, Shuaiyin
    Jin, Yuefei
    Ji, Wangquan
    Zhang, Weiguo
    Duan, Guangcai
    VIRUSES-BASEL, 2021, 13 (10):
  • [34] Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients
    Varun K. Phadke
    Nicholas Scanlon
    Stanley C. Jordan
    Nadine G. Rouphael
    Current Transplantation Reports, 2021, 8 : 127 - 139
  • [35] Global dynamics of SARS-CoV-2/cancer model with immune responses
    Elaiw, A. M.
    Al Agha, A. D.
    APPLIED MATHEMATICS AND COMPUTATION, 2021, 408
  • [36] Study of the cellular and humoral immune responses to SARS-CoV-2 vaccination
    Montmaneix-Engels, Faustine
    Dimeglio, Chloe
    Staes, Laeticia
    Da Silva, Isabelle
    Porcheron, Marion
    Jougla, Isabelle
    Herin, Fabrice
    Izopet, Jacques
    HELIYON, 2024, 10 (07)
  • [37] Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?
    Guillon, A.
    Hiemstra, P. S.
    Si-Tahar, M.
    INTENSIVE CARE MEDICINE, 2020, 46 (10) : 1897 - 1900
  • [38] Special Issue "SARS-CoV-2 Innate and Adaptive Immune Responses"
    Planes, Remi
    Bahraoui, Elmostafa
    VIRUSES-BASEL, 2022, 14 (11):
  • [39] Primary and Recall Immune Responses to SARS-CoV-2 in Breakthrough Infection
    D'Orso, Silvia
    Pirronello, Marta
    Verdiani, Alice
    Rossini, Angelo
    Guerrera, Gisella
    Picozza, Mario
    Sambucci, Manolo
    Misiti, Andrea
    De Marco, Lorenzo
    Salvia, Antonino
    Caltagirone, Carlo
    Giardina, Emiliano
    Battistini, Luca
    Borsellino, Giovanna
    VACCINES, 2023, 11 (11)
  • [40] Silent battles: immune responses in asymptomatic SARS-CoV-2 infection
    Nina Le Bert
    Taraz Samandari
    Cellular & Molecular Immunology, 2024, 21 : 159 - 170
12345